Update on Pancreaticobiliary Diseases 2023

Pancreatic and biliary diseases include a large variety of pathologies, including both benign and malignant diseases, whose diagnosis and management remain a challenge to clinicians. Recent developments and improvements in diagnostic tools and treatment options make this an exciting time for the field. This one-day symposium highlights the full spectrum of multidisciplinary care including advanced imaging, endoscopic approaches, and surgical interventions. We will review the latest advances in interventional endoscopic techniques in patients with pancreatic cancer and cholangiocarcinoma, review updated guidelines on screening for pancreatic cancer, discuss the role of ctDNA testing in HPB malignancies, and highlight current multi-disciplinary treatment strategies for treatment of pancreatic cancer. Finally, the course will emphasize case-based panels that will discuss the application of new technologies and approaches in specific patient cases.

Registration is Closed and onsite registration will open on Saturday, February 11, 2023 at 7:00AM 

1. Explain the recent guidelines and role of germline genetic testing in patients with pancreatic cancer.
2. Differentiate the role of resection and hepatic transplant for patients with hilar cholangiocarcinoma.
3. Identify the role of ctDNA in diagnosis and management of patients with pancreatic cancer.
4. Distinguish the patients for whom pancreatic cancer screening is currently recommended.
5. Describe the variety of endoscopic approached to the ampulla and how to approach difficult polyps.
6. Define the presentation patterns of choledochal cysts and the outcomes of their surgical management.
7. Categorize the role of surgical and percutaneous interventions in the management of pancreatic body tumors involving the celiac axis.
8. Identify the roles and responsibilities of members of the healthcare team involved in the collaborative care of patients with pancreatic cancer.
9. Integrate a team-based approach in the care of patients with pancreatic cancer.

Please contact [email protected] or (833) 731-1273 for registration assistance

Physician: $250
Resident or Fellow: $100
Physician Assistant: $100
Nurse Practitioner: $100
Nurse: $100
Allied Health Professional: $100
Medical Student: $100
Industry Professional: $325

In support of improving patient care, MedStar Health is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE) and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation Statement

 This activity was planned by and for the healthcare team, and learners will receive 6.00 Interprofessional Continuing Education (IPCE) credits for learning and change.

Physicians: MedStar Health designates this live activity for a maximum of 6.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

American Board of Internal Medicine MOC Credit

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 6.00 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

American Board of Surgery CC Credit

Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn credit toward the CME and Self-Assessment requirements of the American Board of Surgery’s Continuous Certification program. It is  the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABS credit.

MOC Participation Threshold
Learner participates by writing a reflective statement and makes a commitment to change or maintain an element of practice.

Physician Assistants:

MedStar Health has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 6.00 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

Nurses: This activity is approved for 6.00 ANCC contact hours. Nurses should claim only the credit commensurate with the extent of their participation in the activity.

The Ritz-Carlton, Washington D.C.
1150 22nd St NW
Washington, D.C. 20037
(202) 835-0500
https://www.ritzcarlton.com/en/hotels/washington-dc/dc

Mitigation of Relevant Financial Relationships

MedStar Health adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education.

Individuals in a position to control the content of this CE activity, including faculty, planners, reviewers, or others are required to disclose all relevant financial relationships with ineligible companies. An ineligible company is any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All of the relevant financial relationships listed below have been mitigated prior to the commencement of the activity.

Faculty Member Information

Role in activity

Name of Ineligible Company(s) / Nature of Relationship(s)

Nadim G. Haddad, MD
System Physician Executive Director, GI Services, Chief of Gastroenterology
MedStar Georgetown University Hospital
Washington, D.C.

Activity Co-Director Content Reviewer, Faculty

Nothing to disclose

Emily R. Winslow, MD
Regional Chief, Hepatopancreaticobiliary Surgery
MedStar Georgetown University Hospital
Washington, D.C.

Activity Co-Director Content Reviewer, Faculty

Nothing to disclose

Reena C. Jha, MD
Radiologist, Division of Abdominal Imaging, Director of Hepatic, Pancreatic and Biliary Imaging, Professor, Radiology and Surgery
MedStar Georgetown University Hospital, Georgetown University School of Medicine
Washington, D.C.

Activity Co-Director, Faculty

Nothing to disclose

Samer C. Charbel, MD
Director of GI and Endoscopy Services, Advanced Biliary Endoscopy
MedStar Montgomery Medical Center, MedStar Washington Hospital Center
Washington, D.C.

Faculty

Nothing to disclose

B. Joseph Elmunzer, MD
Peter Cotton Professor of Medicine and Endoscopic Innovation Division of Gastroenterology and Hepatology
Medical University of South Carolina
Charleston, SC

Faculty

Nothing to disclose

Ross Filice, MD
Chief, Imaging Informatics Department of Radiology
MedStar Georgetown University Hospital, MedStar Medical Group
Washington, D.C.

Faculty

Honoraria-GE Healthcare (Relationship has ended)|Honoraria-Koios Medical (Relationship has ended)|Advisor-BunkerHill Health|Honoraria-Falk Foundation (Relationship has ended)

Thomas M. Fishbein, MD
Executive Director, Director, Liver Diseases and Transplant Program, Professor, Surgery and Pediatrics
MedStar Georgetown Transplant Institute, MedStar Georgetown University Hospital, Georgetown University School of Medicine
Washington, D.C.

Faculty

Nothing to disclose

Aiwu Ruth R. He, MD
Gastrointestinal Medical Oncologist
MedStar Georgetown University Hospital
Washington, D.C.

Faculty

Grant or research support-Merck (Merck Sharp & Donhme a subsidiary of Merck & Co, Inc.)|Grant or research support-Genentech, Inc.|Speakers Bureau-Eisai|Speakers Bureau-BMS

Priyanka Kanth, MD
Associate Professor of Medicine, Division of Gastroenterology
MedStar Georgetown University Hospital, Lombardi Comprehensive Cancer Center
Washington, D.C.

Faculty

Nothing to disclose

Thomas M. Loughney, MD
Director, Endoscopy, Associate Professor, Medicine
MedStar Georgetown University Hospital, Georgetown University Medical Center
Washington, DC

Faculty

Nothing to disclose

John L. Marshall, MD
Director, The Ruesch Center for the Cure of GI Cancers; Frederick P. Smith Endowed Chair; Chief, Hematology and Oncology
Georgetown Lombardi Comprehensive Cancer Center, Georgetown University Medical Center
Washington, D.C.

Faculty

Honoraria-Pfizer, Inc.|Honoraria-Merck|Advisor-Caris|Advisor-Astra Zeneca Astra Zeneca|Advisor-Bayer Corporation|Advisor-Taiho Oncology|Advisor-Merck|Advisor-Pfizer, Inc.|Employment-Indivumed|Honoraria-Daiichi Sankyo, Inc. (Relationship has ended)|Advisor-Seagen|Advisor-Caris

Reetu Mukherji, MD
Gastrointestinal Medical Oncologist, Assistant Professor of Medicine
MedStar Georgetown University Hospital, Georgetown University School of Medicine
Washington, D.C.

Faculty

Grant or research support-Natera|Grant or research support-Genentech, Inc.

Marcus S. Noel, MD
Associate Professor of Medicine
Georgetown Lombardi Comprehensive Cancer Center, MedStar Georgetown University Hospital
Washington, D.C.

Faculty

Consulting Fee-Ipsen (Relationship has ended)

Eileen M. O'Reilly, MD
Medical Oncolgoist, Winthrop Rockefeller Endowed Chair, Co-Director Medical Initiatives, Section Head Hepatopancreaticobiliary & Neuroendocrine Cancers
David M. Ruvenstein Center for Pancreatic Cancer Research, Memorial Sloan Kettering Cancer Center
New York, NY

Faculty

Grant or research support-Genentech, Inc.|Grant or research support-Celgene (Relationship has ended)|Grant or research support-BioNTech|Grant or research support-AstraZeneca AstraZeneca|Grant or research support-Arcus|Grant or research support-Elicio|Grant or research support-Parker Institute|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Rafael Therapeutics (Relationship has ended)|Membership on Advisory Committees or Review Panels, Board Membership, etc.-CytomX (Relationship has ended)|Consulting Fee-Seagen (Relationship has ended)|Consulting Fee-Boehringer-Ingelheim (Relationship has ended)|Consulting Fee-Ipsen|Consulting Fee-Merck|Consulting Fee-IDEAYA (Relationship has ended)|Consulting Fee-Silenseed|Consulting Fee-AstraZeneca AstraZeneca|Advisor-Novartis Pharmaecuticals|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Astellas|Advisor-Neogene (Relationship has ended)|Advisor-BMS|Advisor-Tempus|Advisor-Fibrogen|Advisor-Novocure

Pejman Radkani, MD
Surgeon, Hepatopancreatobiliary and GI Surgical Oncologist, Transplant Surgeon, Assistant Professor, Surgery
MedStar Georgetown University Hospital, MedStar Washington Hospital Center, Georgetown University School of Medicine
Washington, D.C.

Faculty

Nothing to disclose

Mark J. Real, MD, Physician
Interventional Gastroenterologist
MedStar Southern Maryland Hospital, MedStar St. Mary's Hospital
Clinton, MD

Faculty

Nothing to disclose

Abhinav Sankineni, MD, MPH
Director, Endoscopy, Center for Digestive Disease
MedStar Franklin Square Medical Center
Baltimore, MD

Faculty

Nothing to disclose

John B. Smirniotopoulos, NA
Vascular and Interventional Radiologist, Assistant Professor Radiology
MedStar Washington Hospital Center, MedStar Georgetown University Hospital
Washington, D.C.

Faculty

Consulting Fee-Zimmer Biomet|Consulting Fee-Boston Scientific Boston Scientific Boston Scientific

Keith R. Unger, MD
Director, Gastrointestinal Cancer Service, Professor, Radiation Medicine
MedStar Georgetown University Hospital, Georgetown University School of Medicine
Washington, D.C.

Faculty

Honoraria-MEVION medical systems (Relationship has ended)

Walid M. Chalhoub, MD
Site Director, Division Chief of Gastroenterology, Co-Director Advanced Endoscopy, Assistant Professor of Medicine
MedStar Southern Maryland Hospital Center, MedStar Georgetown University Hospital, Georgetown University Medical Center
Washington, D.C.

Faculty, Planning Committee Member

Nothing to disclose

Jacqueline A O'Rourke, PA
MGUH
Washington, D.C.

Planning Committee Member

Nothing to disclose

Meggin A. Sabatino, Other
MedStar Georgetown University Hospital
Washington , D.C.

Planning Committee Member

Nothing to disclose

Saturday, February 11, 2023

Please contact Elizabeth Romano at [email protected] for information on exhibiting at this conference.